Home › Funds › Casdin Capital › BLFS
Casdin Capital position in BLFS
BIOLIFE SOLUTIONS INC · Health Care
Latest position (Q2 2026)4.66M sh
Reported value held$131.46M
Portfolio Weight6.58%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 7.57M | $320.20M | New |
| Q4 2021 | 7.57M | $282.00M | Hold |
| Q1 2022 | 7.57M | $171.98M | Hold |
| Q2 2022 | 7.57M | $104.49M | Hold |
| Q3 2022 | 7.57M | $172.13M | Hold |
| Q4 2022 | 7.57M | $137.74M | Hold |
| Q1 2023 | 7.57M | $164.68M | Hold |
| Q2 2023 | 7.72M | $170.65M | Add |
| Q3 2023 | 7.78M | $107.44M | Add |
| Q4 2023 | 8.71M | $141.49M | Add |
| Q1 2024 | 8.71M | $161.52M | Hold |
| Q2 2024 | 8.71M | $186.59M | Hold |
| Q3 2024 | 8.71M | $218.03M | Hold |
| Q4 2024 | 8.71M | $226.04M | Hold |
| Q1 2025 | 8.71M | $198.87M | Hold |
| Q2 2025 | 7.71M | $166.01M | Reduce |
| Q3 2025 | 6.71M | $171.10M | Reduce |
| Q4 2025 | 5.96M | $144.04M | Reduce |
| Q1 2026 | 5.96M | $113.66M | Hold |
| Q2 2026 | 4.66M | $131.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BLFS
- BlackRock Inc 6.38M sh · $180.05M · Q2 2026
- Vanguard Group 3.09M sh · $74.65M · Q4 2025
- Invesco Ltd 2.24M sh · $63.27M · Q2 2026
- Geode Capital Management 1.09M sh · $30.70M · Q2 2026
- MFS Investment Management 1.08M sh · $30.48M · Q2 2026
- Fidelity Management & Research (FMR) 993.11K sh · $28.05M · Q2 2026
- Bank of America Corp 950.16K sh · $26.83M · Q2 2026
- UBS Group AG 832.14K sh · $23.50M · Q2 2026
- Millennium Management 675.66K sh · $19.08M · Q2 2026
- Royce & Associates 623.88K sh · $17.62M · Q2 2026
- Goldman Sachs Group 569.08K sh · $16.07M · Q2 2026